CG Oncology Inc. Common s... (CGON)
NASDAQ: CGON
· Real-Time Price · USD
25.71
-0.25 (-0.96%)
At close: Aug 15, 2025, 3:59 PM
25.70
-0.04%
After-hours: Aug 15, 2025, 04:54 PM EDT
CG Oncology Common stock Balance Sheet Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q1 2023 | Q4 2022 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Mar 31, 2023 | Dec 31, 2022 |
Cash & Equivalents | 14.62M | 41.47M | 257.07M | 43.41M | 25.16M | 77.47M | 8.27M | 10.27M | -143.48M | 88.14M |
Short-Term Investments | 646.43M | 646.96M | 484.93M | 497.3M | 527.72M | 489.04M | 179.41M | 193.48M | 286.96M | 55.34M |
Long-Term Investments | 26.68M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 522K | 25.69M | 94K | 53K | 53K | 53K | 4.69M | 1.63M | -143.48M | 33K |
Receivables | 562K | 345K | 781K | 137K | 182K | 153K | 92K | 1K | n/a | 303K |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 11.42M | 12.41M | 11.43M | 11.23M | 10.8M | 11.95M | 6.36M | 5.96M | n/a | 3.42M |
Total Current Assets | 673.03M | 701.19M | 754.21M | 552.08M | 563.86M | 578.61M | 194.12M | 209.71M | 143.48M | 147.21M |
Property-Plant & Equipment | 1.22M | 1.3M | 493K | 338K | 413K | 445K | 491K | 550K | n/a | 506K |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 28.41M | 26.99M | 587K | 391K | 466K | 498K | 5.18M | 2.18M | -143.48M | 539K |
Total Assets | 701.45M | 728.18M | 754.8M | 552.47M | 564.33M | 579.11M | 199.3M | 211.88M | n/a | 147.75M |
Account Payables | 7.13M | 6.73M | 6.52M | 4.08M | 4.49M | 4.66M | 3.24M | 1.96M | n/a | 985K |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 288K | n/a | n/a | n/a | 237K | 220K | 569K | n/a | n/a | 8.97M |
Other Current Liabilities | 18.41M | 2.82M | 436K | 5.02M | 4.37M | 3.13M | 547K | 1.07M | n/a | 173K |
Total Current Liabilities | 30.38M | 22.64M | 21.37M | 15.63M | 11.85M | 9.98M | 14.25M | 11.7M | n/a | 15.43M |
Long-Term Debt | 706K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 6.53M |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | 13K | 13K | n/a | 352K |
Total Long-Term Liabilities | 706K | 781K | 52K | 71K | 118K | 184K | 257K | 308.2M | n/a | 7.14M |
Total Liabilities | 31.09M | 23.42M | 21.42M | 15.7M | 11.97M | 10.17M | 14.51M | 319.91M | n/a | 22.57M |
Total Debt | 994K | 1.04M | 238K | 296K | 355K | 404K | 461K | 517K | n/a | 16.3M |
Common Stock | 8K | 8K | 8K | 7K | 7K | 7K | n/a | 1K | n/a | n/a |
Retained Earnings | -293.86M | -252.43M | -217.98M | -186.18M | -165.78M | -146.87M | -129.94M | -113.83M | n/a | -81.33M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -77.69M | n/a |
Shareholders Equity | 670.36M | 704.76M | 733.38M | 536.77M | 552.36M | 568.94M | 184.79M | -108.02M | 125.18M | 125.18M |
Total Investments | 673.1M | 646.96M | 484.93M | 497.3M | 527.72M | 489.04M | 179.41M | 193.48M | 286.96M | 55.34M |